Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic

Abstract Objective To examine the relative benefits and disadvantages of non-steroidal anti-inflammatory drugs (NSAIDs) and opioids for the management of acute renal colic. Data sources Cochrane Renal Group's specialised register, Cochrane central register of controlled trials, Medline, Embase,...

Full description

Saved in:
Bibliographic Details
Published inBMJ Vol. 328; no. 7453; pp. 1401 - 1404
Main Authors Holdgate, Anna, Pollock, Tamara
Format Journal Article
LanguageEnglish
Published London British Medical Journal Publishing Group 12.06.2004
BMJ Publishing Group
British Medical Association
BMJ Publishing Group LTD
BMJ Publishing Group Ltd
EditionInternational edition
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Objective To examine the relative benefits and disadvantages of non-steroidal anti-inflammatory drugs (NSAIDs) and opioids for the management of acute renal colic. Data sources Cochrane Renal Group's specialised register, Cochrane central register of controlled trials, Medline, Embase, and reference lists of retrieved articles. Review methods Randomised controlled trials comparing any opioid with any NSAID in acute renal colic if they reported any of the following outcomes: patient rated pain, time to pain relief, need for rescue analgesia, rate of recurrence of pain, and adverse events. Results 20 trials totalling 1613 participants were identified. Both NSAIDs and opioids led to clinically important reductions in patient reported pain scores. Pooled analysis of six trials showed a greater reduction in pain scores for patients treated with NSAIDs than with opioids. Patients treated with NSAIDs were significantly less likely to require rescue analgesia (relative risk 0.75, 95% confidence interval 0.61 to 0.93). Most trials showed a higher incidence of adverse events in patients treated with opioids. Compared with patients treated with opioids, those treated with NSAIDs had significantly less vomiting (0.35, 0.23 to 0.53). Pethidine was associated with a higher rate of vomiting. Conclusions Patients receiving NSAIDs achieve greater reductions in pain scores and are less likely to require further analgesia in the short term than those receiving opioids. Opioids, particularly pethidine, are associated with a higher rate of vomiting.
Bibliography:istex:D402C0ED11FDF8DCA311C3251A1781CD48DE8D6D
ark:/67375/NVC-FT696704-R
ArticleID:bmj.38119.581991.55
href:bmj-328-1401.pdf
PMID:15178585
Correspondence to: A Holdgate
local:bmj;328/7453/1401
Ethical approval: Not required.
This review was conducted with substantial support and advice from the Cochrane Renal Group, Sydney, Australia.
Contributors: AH and TP were involved in all stages of study design, data collection, data analysis, and manuscript preparation. AH will act as guarantor for the paper.
Correspondence to: A Holdgate holdgatean@sesahs.nsw.gov.au
Competing interests: None declared.
ISSN:0959-8138
0959-8146
1468-5833
1756-1833
DOI:10.1136/bmj.38119.581991.55